Distinguished in Pancreatic Islet Cell Tumor

Lucy R. Wall

Crewe Road, South, 
Edinburgh, SCT, GB 
Distinguished in Pancreatic Islet Cell Tumor
Crewe Road, South, 
Edinburgh, SCT, GB 
OverviewLocationsClinical Research

Overview

Lucy Wall practices in Edinburgh, United Kingdom. Ms. Wall is rated as a Distinguished expert by MediFind in the treatment of Pancreatic Islet Cell Tumor. Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Embryonal Tumor with Multilayered Rosettes, and Cholangiocarcinoma (Bile Duct Cancer).

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Pancreatic Islet Cell Tumor.

Gender
Female

Locations

Crewe Road, South, Edinburgh, SCT, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Without Tislelizumab in Subjects With HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)
A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Without Tislelizumab in Subjects With HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)
Enrollment Status: Active_not_recruiting
Publish Date: September 25, 2025
Intervention Type: Drug
Study Drugs: Zanidatamab, Tislelizumab, Trastuzumab, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil
Study Phase: Phase 3
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2025
Intervention Type: Drug
Study Drugs: Gemcitabine, Cisplatin, Capecitabine
Study Phase: Phase 3
Early Support in Primary Care for People Starting Treatment for Cancer
Early Support in Primary Care for People Starting Treatment for Cancer
Enrollment Status: Completed
Publish Date: March 09, 2021
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trials

16 Total Publications

Adrenocortical carcinoma: selective internal radiation therapy and liver metastases.
Adrenocortical carcinoma: selective internal radiation therapy and liver metastases.
Journal: Endocrine oncology (Bristol, England)
Published: November 14, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Wall's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile